Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield

Transfusion

Volumn 51, Issue 9, 2011, Pages 2012-2022

  Stramer, Susan L ^a,b,c,d,e,f   Krysztof, David E ^a,b,c,d,e,f   Brodsky, Jaye P ^a,b,c,d,e,f   Fickett, Tracy A ^a,b,c,d,e,f   Reynolds, Benjamin ^a,b,c,d,e,f   Phikulsod, Soisaange ^a,b,c,d,e,f   Oota, Sineeart ^a,b,c,d,e,f   Lin, Matthew ^a,b,c,d,e,f   Saldanha, John ^a,b,c,d,e,f   Kleinman, Steven H ^a,b,c,d,e,f  

^a AMERICAN RED CROSS   (United States)

^b Quality Analytics   (United States)

^c CREATIVE TESTING SOLUTIONS   (United States)

^d THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^e ROCHE MOLECULAR SYSTEMS   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; COMPARATIVE STUDY; CONTROLLED STUDY; FOOD AND DRUG ADMINISTRATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MULTIPLEX NUCLEIC ACID TEST SYSTEM; NONHUMAN; QUANTITATIVE ANALYSIS; THAILAND; UNITED STATES; VIRUS DETECTION; VIRUS LOAD;

DNA, VIRAL; HEPATITIS B VIRUS; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80052530800     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03140.x     Document Type: Article

References (28)

1. Allain JP,. Occult hepatitis B infection: implications in transfusion. Vox Sang 2004; 86: 83-91.
2. Hollinger FB,. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008; 48: 1001-26. (Pubitemid 351614923)
3. Hollinger FB, Sood G,. Occult hepatitis B virus infection: a covert operation. J Viral Hepat 2010; 17: 1-15.
4. Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Praphan Phanuphak P, Wasi C, Nuchprayoon C,; The Working Group for NAT Study in Thai Blood Donations. One-year experience of nucleic acid technology testing for human immunodeficiency virus type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009; 49: 1126-35.
5. Stramer SL, Wend U, Condotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W,. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 2011; 364: 31-42.
6. Linauts S, Saldanha J, Strong DM,. PRISM hepatitis B surface antigen detection of hepatitis B virus minipool nucleic acid yield samples. Transfusion 2008; 48: 1376-82.
7. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Misogushi H,. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007; 47: 1162-71. (Pubitemid 46934305)
8. Satake M, Taira R, Yugi H, Hino S. Kanemitsu K, Ikeda H, Tadokoro K,. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47: 1197-205. (Pubitemid 46934327)
9. Tabuchi A, Tanaka J, Katayama K, Mizui M, Matsukura H, Yugi H, Shimada T, Miyakawa Y, Yoshizawa H,. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiements to chimeric mice with human liver repopulated hepatocytes. J Med Virol 2008; 80: 2064-8.
10. Manzini P, Abate ML, Valpreda C, Milanesi P, Curti F, Rizzetto M, Smedile A,. Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor. Transfusion 2009; 49: 757-64.
11. Bremer CM, Saniewski M, Wend UC, Torres P, Lelie N, Gerlich W,. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009; 49: 1621-29.
12. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP,. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008; 48: 1022-5.
13. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, David B, De Micco P,. Comparison of the analytical and operational performance of two automated NAT blood screening systems: Procleix TIGRIS and cobas s 201. Transfusion 2009; 49: 289-300.
14. Gen-Probe, Incorporated. Procleix" Ultrio" Assay product insert: 501807 Rev. 3. 2009-10. San Diego, CA, USA.
15. Roche Molecular Systems, Inc. cobas" TaqScreen MPX Test for use on the cobas s 201 System product insert: 1636, Rev 4 2009. Indianapolis, NJ, USA.
16. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P,. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels. Transfusion 2009; 49: 301-10.
17. Margaritis AR, Brown SM, Seed CR, Kiely P, DAgostino B, Keller AJ,. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 2007; 47: 1783-93. (Pubitemid 47438540)
18. Louisirirotchanakul S, Oota S, Khuponsarb K, Chalernchan W, Phikulsod S, Chongkolwatana V, Sakuldamrongpanish T, Kitpoka P, Chielsilp P, Tirawatnapong T, Wasi C, and the Working Group for NAT Study in Thai Blood Donations. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011; 51: 1532-40.
19. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP,. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003; 43: 788-98. (Pubitemid 36629125)
20. Kleinman SH, Busch MP,. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006; 36 Suppl 1: S23-9. (Pubitemid 44016154)
21. Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, Fang CT, Dodd RY,. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009; 49: 1609-20.
22. Marshall DA, Kleinman SH, Wong JB, Aubuchon JP, Grima DT, Kulin NA, Weinstein MC,. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C, and human immunodeficiency virus in the United States. Vox Sang 2004; 86: 28-40. (Pubitemid 38200453)
23. Jackson BR, Busch MP, Stramer SL, Aubuchon JP,. The cost-effectiveness of NAT for HIV, HCV and HBV in whole blood donations. Transfusion 2003; 43: 721-9. (Pubitemid 36629116)
24. Gen-Probe, Incorporated. Procleix" Ultrio" Plus Assay product insert: 501510EN, Rev. D. 2010. San Deigo, CA, USA.
25. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, MP B,; Retrovirus Epidemiology Donor Study. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43: 696-704. (Pubitemid 36629113)
26. McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H. Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW,. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009; 200: 1390-6.
27. Chu CJ, Keeffe EB, Han SF, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS Jr, Luketic VA, Terrault N, Lok AS,. Hepatitis B virus genotypes in the United States: results of a nationwide survey. Gastroenterology 2003; 125: 444-51. (Pubitemid 36929426)
28. Echevarria JM, Avellon A,. Hepatitis B virus genetic diversity. J Med Virol 2006; 78: S36-42. (Pubitemid 43993463)